News | Treatment Planning | April 24, 2018

Brainlab Introduces New Hi-Res Planning Algorithm for VersaHD

Automatic support of virtual leaves in Elements offers improved dose conformity in radiosurgery

Brainlab Introduces New Hi-Res Planning Algorithm for VersaHD

April 24, 2018 — Brainlab announced the implementation of a software solution that can achieve better radiation therapy dose conformity around brain tumors, resulting from a close strategic collaboration with Elekta. Brainlab Elements take advantage of the specific properties of Elekta’s Agility multileaf collimator and compensates for the width of selected leaves, enabling the radiation beam to more accurately conform to the tumor’s shape, thereby minimizing dose to organs at risk.

A new treatment planning algorithm in Brainlab Elements cranial radiosurgery software supports virtual leaf width capability with Agility on the Versa HD linear accelerator. Through the dynamic manipulation of the Y-Jaws, the algorithm partially blocks the collimator leaves along the vertical edge of a tumor target, which can reduce the collimator leaf down to 1 mm across the full treatment field of view for enhanced conformity.

Elekta also has an ongoing interoperability program with Brainlab that will ensure integration of ExacTrac 5.x and 6.x as well as future versions.

The new enhanced capability supporting VersaHD builds on the success of existing collaborations between Elekta and Brainlab, like the jointly marketed Leksell Vantage Stereotactic System with Elements Stereotaxy, as well as the integration of Versa HD and Brainlab ExacTrac patient positioning and monitoring technology.

For more information: www.brainlab.com

 

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...